Ocular Therapeutix, Inc.
NASDAQOCUL cost to borrow surges 116% in one week to 1.07%, highest level in recent trading as borrow demand intensifies amid 12.3% short interest.
Snapshot as of 22 Jun 2026
Ocular Therapeutix has passed through its June 17 readout event and the bullish options positioning that preceded it has begun to normalise — leaving the stock at $8.94 with a more mixed set of signals than the…
Ocular Therapeutix heads into a pivotal stretch with options traders at their most bullish in months — and a formal readout event just days away. The sharpest signal this week is in options. The put/call ratio has…
Ocular Therapeutix reported Q1 results on May 5 that landed below expectations on every line — EPS of -$0.40 missed the -$0.33 estimate, and revenue of $10.8 million trailed the $12.6 million consensus. The stock…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OCUL — free to start on ORTEX.
Sign up for free →Open OCUL on ORTEX